|本期目录/Table of Contents|

[1]刘晓智 综述,杨新宇 审校.小泛素样修饰体在神经系统疾病中的功能研究进展[J].天津医科大学学报,2017,23(03):280-283.
点击复制

小泛素样修饰体在神经系统疾病中的功能研究进展(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
23卷
期数:
2017年03期
页码:
280-283
栏目:
综述
出版日期:
2017-05-18

文章信息/Info

Title:
-
文章编号:
1006-8147(2017)03-0280-04
作者:
刘晓智 综述杨新宇 审校
(天津医科大学总医院神经外科,天津市神经病学研究所,天津 300052)
Author(s):
-
关键词:
小泛素样修饰体脑卒中神经退行性疾病脑肿瘤
Keywords:
-
分类号:
R651
DOI:
-
文献标志码:
A
摘要:
-
Abstract:
-

参考文献/References:

[1] 朱贺,陈思娇.核因子κB及其SUMO化调控与糖尿病肺改变[J].医学综述, 2012,18(8):1143

[2] Mendler L, Braun T, Müller S.The Ubiquitin-Like SUMO System and Heart Function: From Development to Disease[J]. Circ Res,2016,118(1):132

[3] Ulrich HD.Two-way communications between ubiquitin-like modifiers and DNA[J].Nat Struct Mol Biol. 2014,21(4):317

[4] 杨红艳,陈婕.2型糖尿病核因子κB信号通路相关微血管内皮损伤与SUMO化修饰[J].医学综述,2012,18(7):1077

[5] Liu X, Wang Q, Chen W, et al.Dynamic regulation of innate immunity by ubiquitin and ubiquitin-like proteins[J].Cytokine Growth Factor Rev. 2013,24(6):559

[6] Raman N, Nayak A, Muller S.The SUMO system: a master organizer of nuclear protein assemblie[J]s.Chromosoma. 2013,122(6):475

[7] Watts FZ.Starting and stopping SUMOylation. What regulates the regulator? [J].Chromosoma. 2013,122(6):451

[8] Eifler K, Vertegaal AC.SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer[J]. Trends Biochem Sci,2015,40(12):779

[9] Nuro-Gyina PK, Parvin JD.Roles for SUMO in pre-mRNA processing[J]. Wiley Interdiscip Rev RNA,2016,7(1):105

[10] Jackson SP, Durocher D.Regulation of DNA damage responses by ubiquitin and SUMO[J].Mol Cell. 2013,49(5):795

[11] Campello L, Esteve-Rudd J, Cuenca N, et al.The ubiquitin-proteasome system in retinal health and disease[J].Mol Neurobiol. 2013,47(2):790

[12] Kirton A, Deveber G. Life after perinatal stroke[J].Stroke, 2013,44(11): 3265

[13] 魏亮.急性缺血性脑血管病的治疗现状和进展[J].医学综述,2014,20(16):2948

[14] Lee YJ, Castri P, Bembry J, et al.SUMOylation participates in induction of ischemic tolerance[J].J Neurochem. 2009,109(1):257

[15] Yang W, Thompson JW, Wang Z, et al. Analysis of oxygen/glucose-deprivation-induced changes in SUMO3 conjugation using SILAC-based quantitative proteomics[J]. J Proteome Res, 2012,11(2): 1108

[16] Hoppe JB, Salbego CG, Cimarosti H.SUMOylation: Novel Neuroprotective Approach for Alzheimer’s Disease?[J]. Aging Dis,2015,6(5):322

[17] Girach F, Craig TJ, Rocca DL, et al. RIM1α SUMOylation is required for fast synaptic vesicle exocytosis[J]. Cell Rep,2013,5(5):1294

[18] Feliciano P, Andrade R, Bykhovskaia M. Synapsin II and Rab3a cooperate in the regulation of epileptic and synaptic activity in the CA1 region of the hippocampus[J]. J Neurosci, 2013,33(46): 18319

[19] Nisticò R, Ferraina C, Marconi V, et al. Age-related changes of protein SUMOylation balance in the AβPP Tg2576 mouse model of Alzheimer’s disease[J]. Front Pharmacol. 2014,5(4):63

[20] Guerra de Souza AC, Prediger RD, Cimarosti H.SUMO-regulated mitochondrial function in Parkinson’s disease[J]. J Neurochem,2016,137(5):673

[21] Vijayakumaran S, Wong MB, Antony H, et al. Direct and/or Indirect Roles for SUMO in Modulating Alpha-Synuclein Toxicity[J]. Biomolecules,2015,5(3):1697

[22] Cho SJ, Yun SM, Jo C, et al. SUMO1 promotes Aβ production via the modulation of autophagy[J]. Autophagy, 2015,11(1):100

[23] Cho SJ, Yun SM, Lee DH, et al. Plasma SUMO1 Protein is Elevated in Alzheimer’s Disease[J]. J Alzheimers Dis, 2015,47(3):639

[24] Chen T, Liao XP, Wen GQ, et al.The effect of small ubiquitin-like modifier-1 modification on the formation of Lewy body-like inclusions in cytoplasm and apoptosis of HEK293 cell induced by overexpression and mutation of alpha-synuclein[J].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011,28(5):511

[25] Janer A, Werner A, Takahashi-Fujigasaki J, et al. SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7[J]. Hum Mol Genet. 2010,19(1):181

[26] Kang S, Hong S. SUMO-1 interacts with mutant ataxin-1 and colocalizes to its aggregates in Purkinje cells of SCA1 transgenic mice[J]. Arch Ital Biol. 2010,148(4):351

[27] Mei D, Song H, Wang K, et al.Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association[J].Med Oncol. 2013,30(4):709

[28] Wang CM, Liu R, Wang L, et al. SUMOylation of FOXM1B alters its transcriptional activity on regulation of MiR-200 family and JNK1 in MCF7 human breast cancer cells[J]. Int J Mol Sci. 2014,15(6):10233

[29] Yang H, Tang Y, Guo W, et al.Up-regulation of microRNA-138 induce radiosensitization in lung cancer cells[J].Tumour Biol. 2014,35(7):6557

[30] Yang W, Wang L, Roehn G, et al. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival[J]. Cancer Sci. 2013,104(1):70

[31] Wasik U, Filipek A. The CacyBP/SIP protein is sumoylated in neuroblastoma NB2a cells[J]. Neurochem Res. 2013,38(11):2427

[32] Bellail AC, Olson JJ, Hao C. SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression[J]. Nat Commun,2014,5(6):1

[33] Han W, Wang L, Yin B, et al. Characterization of a novel posttranslational modification in polypyrimidine tract-binding proteins by SUMO1[J]. BMB Rep,2014,47(4):233

[34] Wang L, Zhang J, Banerjee S, Barnes L, et al. Sumoylation of vimentin354 is associated with PIAS3 inhibition of glioma cell migration[J]. Oncotarget,2010,1(7):620

[35] Cube?as-Potts C, Matunis MJ.SUMO: a multifaceted modifier of chromatin structure and function[J].Dev Cell. 2013,24(1):1

相似文献/References:

[1]高伟,傅强.卒中相关性肺炎病原菌分布、耐药情况及危险因素分析[J].天津医科大学学报,2020,26(02):138.
 GAO Wei,FU Qiang.Distribution, drug resistance and risk factors of pathogenic bacteria in patients with stroke-associated pneumonia[J].Journal of Tianjin Medical University,2020,26(03):138.
[2]姜国晶,齐雪梅,王仲言,等.弗朗斯维尔市气象因素与疟疾、高血压和脑卒中关系的初步探讨[J].天津医科大学学报,2021,27(03):243.
 JIANG Guo-jing,QI Xue-mei,WANG Zhong-yan,et al.The associations between meteorological factors and malaria,hypertension and stroke in Franceville[J].Journal of Tianjin Medical University,2021,27(03):243.

备注/Memo

备注/Memo:
基金项目 国家自然科学基金面上项目基金资助(81471175); 天津市卫生局科技基金项目(2014KZ017)

作者简介 刘晓智(1979-),男,主治医师,博士在读,研究方向:脑血管病的综合治疗; 通信作者:杨新宇,E-mail:chnxyyang@163.com。

更新日期/Last Update: 2017-05-18